Trial Profile
Results of intravitreal ranibizumab with a prn regimen in the treatment of extrafoveal and juxtafoveal neovascular membranes in age-related macular degeneration.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Nov 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 26 Nov 2015 New trial record